New Jersey A 116: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: A 116

Subjects: DISEASE, HEALTH PROF

Sponsors: DePhillips, Christopher P., Rooney, Kevin J.

View New Jersey A 116 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.